Cook Medical’s Zenith Endograft Captures Leading Market Share Position in Endovascular Aortic Repair Global Market

Built on Patient-Focused Innovation, Company’s Rapidly Growing Business Unit Drives Double-Digit Growth; Forecasts Point to Continued Momentum in 2008 and Beyond

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical today announced that its Aortic Intervention strategic business unit has captured more than 40 percent of the world market share, a leading global position in the endovascular aortic repair (EVAR) market. Through the rapid adoption of its advanced Zenith Endovascular Graft System designed to treat abdominal aortic aneurysms (AAA), the company has gained momentum as physicians, hospitals and other medical institutions have increasingly chosen Zenith as an effective, minimally invasive means of treating potentially life-threatening AAAs.
Cook’s Aortic Intervention SBU has experienced significant growth throughout the past year. For the year to date, the business unit has increased its global sales by 37 percent. As Cook’s current offerings in aortic intervention continue to gain momentum and new products are introduced to market, this growth pattern is predicted to continue in 2008.

read the full article: http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20071115005092&newsLang=en